Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
458 |
| HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
538 |
| HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
80,206 |
| HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
18,798 |
| HTS_TST |
By Test Result: Negative |
2016 |
96,893 |
| HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
100,000 |
| HTS_TST |
Sum of Aggregated Age/Sex <15 |
2016 |
996 |
| HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2016 |
99,004 |
| HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2016 |
100,000 |
| HTS_TST |
Sum of Test Result disaggregates |
2016 |
100,000 |
| HTS_TST_POS |
By Test Result: Positive |
2016 |
3,107 |
| KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
23,939 |
| KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2016 |
23,939 |
| PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2016 |
199 |
| PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2016 |
188 |
| PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2016 |
121 |
| PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2016 |
67 |
| PMTCT_ARV |
Sum of New and Current disaggregates |
2016 |
188 |
| PMTCT_EID |
By infants who received a virologic test within 2 months of birth |
2016 |
143 |
| PMTCT_EID |
By infants who received their first virologic HIV test between 2 and 12 months of age |
2016 |
35 |
| PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2016 |
178 |
| PMTCT_EID |
Sum of Infant Age disaggregates |
2016 |
178 |
| PMTCT_STAT |
By: Known positives at entry |
2016 |
140 |
| PMTCT_STAT |
By: Number of new positives identified |
2016 |
60 |
| PMTCT_STAT |
Number of new ANC and L&D clients |
2016 |
18,839 |
| PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2016 |
17,897 |
| PMTCT_STAT |
Sum of Positives Status disaggregates |
2016 |
200 |
| TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
1,372 |
| TX_NEW |
By Age/Sex: 15-19 Female |
2016 |
16 |
| TX_NEW |
By Age/Sex: 20-24 Female |
2016 |
112 |
| TX_NEW |
By Age/Sex: 25-49 Female |
2016 |
581 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2016 |
1,084 |
| TX_NEW |
Sum of Age/Sex disaggregates |
2016 |
1,084 |
